Mid-America Apartment Communities, Inc. News Headlines

MAA 
$74.29
*  
0.12
  negative  
0.16%
Get MAA Alerts
*Delayed - data as of May 21, 2013 
Exchange: NYSE
Industry: Consumer Services
Community Rating:
 
 

Symbol List Views

Stock Details

CHARTS

COMPANY NEWS

STOCK ANALYSIS

FUNDAMENTALS

HOLDINGS

 Save stocks for next time
 | Sponsored
Viewing
Filtered By
Ordered By

Bayer's Xofigo Cleared in the US - Analyst Blog
5/16/2013 6:30:48 PM - Zacks.com

ARNA Sheds Light on Belviq Launch - Analyst Blog
5/9/2013 4:24:33 PM - Zacks.com

Ariad Posts Wider Y/Y Loss - Analyst Blog
5/8/2013 10:23:32 AM - Zacks.com

Wider-than-Expected Loss at Endocyte - Analyst Blog
5/6/2013 2:18:01 PM - Zacks.com

Arena Pharma Narrows Loss - Analyst Blog
5/6/2013 11:21:53 AM - Zacks.com

Loss at Aegerion Narrower Than Expected - Analyst Blog
5/3/2013 4:29:09 PM - Zacks.com

Mid-America Apartment Communities Q1 13 Earnings Conference Call At 10:00 AM ET
5/2/2013 8:59:00 AM - RTT News

Positive CHMP Opinion for Avanir - Analyst Blog
5/1/2013 10:48:54 AM - Zacks.com

BioMarin Widens Loss, Maintains View - Analyst Blog
4/29/2013 11:50:23 AM - Zacks.com

These 4 Stocks Have Less Profitable Margins Than Peers, But Are Showing Signs Of Improvement
4/12/2013 6:22:00 AM - Seeking Alpha

SNY's Vaxigrip Filing Accepted in EU - Analyst Blog
4/11/2013 7:11:05 PM - Zacks.com

ARNA/Eisai's Belviq Filed in Mexico - Analyst Blog
4/3/2013 4:19:58 PM - Zacks.com

Vivus Opts for Royalty Financing - Analyst Blog
4/2/2013 7:21:59 PM - Zacks.com

Lilly Progresses with Empagliflozin - Analyst Blog
4/1/2013 6:07:01 PM - Zacks.com

Arena Applies For Launch In Mexico
4/1/2013 6:01:00 PM - Seeking Alpha

Astellas' Acofide Approved in Japan - Analyst Blog
3/27/2013 3:27:09 PM - Zacks.com

Gilead's Stribild Backed by CHMP - Analyst Blog
3/25/2013 7:27:47 PM - Zacks.com

Astellas' Candidate Progresses - Analyst Blog
3/14/2013 4:11:19 PM - Zacks.com

J&J Seeks EU Nod for Combo Drug - Analyst Blog
3/11/2013 5:10:42 PM - Zacks.com

Vivus Reports Wider Loss - Analyst Blog
2/26/2013 2:54:01 PM - Zacks.com

Revenues Rise at Endocyte - Analyst Blog
2/26/2013 10:40:01 AM - Zacks.com

Neutral Stance on UDR - Analyst Blog
2/25/2013 6:00:01 PM - Zacks.com

CHMP Still Negative on Vivus' Qsiva - Analyst Blog
2/22/2013 5:15:01 PM - Zacks.com

There's No Place Like Home Properties
2/22/2013 3:45:00 PM - Seeking Alpha

Glaxo/Theravance Seek US Approval - Analyst Blog
2/21/2013 5:00:01 PM - Zacks.com